| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 987,000 | 12,358,000 | 12,380,000 | 13,910,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 12,358,000 | 12,380,000 | 13,910,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 61,312,000 | (5,939,000) | 8,666,000 | 1,647,000 | | Non Recurring |
-
|
-
|
-
| 1,858,000 | | Others |
-
| 26,809,000 | 20,334,000 | 28,649,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (8,512,000) | (16,620,000) | (18,244,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 1,714,000 | | Earnings Before Interest And Taxes | (13,182,000) | (8,512,000) | (16,620,000) | (16,531,000) | | Interest Expense | 5,845,000 | 6,245,000 | 7,188,000 | 8,274,000 | | Income Before Tax | (19,027,000) | (14,757,000) | (23,808,000) | (24,805,000) | | Income Tax Expense | (143,000) | 23,000 | (623,000) | 142,000 | | Minority Interest |
-
|
-
|
-
| (1,000) | | | | Net Income From Continuing Ops | (20,277,000) | (14,780,000) | (23,185,000) | (24,947,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| (280,000) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,829,000) | (14,780,000) | (23,185,000) | (25,227,000) | | Preferred Stock And Other Adjustments | (926,000) | (385,000) | (12,000) | (25,000) | | | Net Income Applicable To Common Shares | ($19,755,000) | ($15,165,000) | ($23,197,000) | ($25,252,000) |
|
1.05% Nasdaq 
Income Statement
